Jun 24, 2019

Cancer patients welcome breakthrough ‘living drug’ that reprograms immune systems to fight disease

Posted by in categories: biotech/medical, genetics, health

In a groundbreaking treatment, cancer patients’ immune systems are being genetically reprogrammed to fight their terminal cancer for them, with promising results.

In the UK, a number of National Health Service (NHS) patients with lymphoma at King’s College Hospital have been given CAR-T, a “living drug” that is unique to each patient as it contains some of their own cells.

Comments are closed.